<unk>  is an inducer of cell death that is FDA approved for the treatment of actinic keratosis.   Common adverse reactions include local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis and headache.
Ingenol mebutate
Degarelix
Nafarelin
Triptorelin pamoate
Talbutal
Gestodene
Quingestanol
Cyproterone